Necrolytic migratory erythema (NME) is a rare skin condition that is characterized by a distinctive red-brown rash. It is most commonly seen in patients with certain types of liver disease, such as cirrhosis or hepatitis. NME can be difficult to diagnose, as its symptoms can be similar to other skin conditions. This article will provide an overview of NME, including its causes, diagnosis, and treatment options.
NME is a skin condition that is characterized by a distinctive red-brown rash. The rash is usually located on the legs and buttocks, but can also be found on the arms, face, and other areas of the body. The rash may be itchy and can be accompanied by other symptoms, such as fatigue and weight loss. The cause of NME is not fully understood, but it is believed to be related to certain types of liver disease, such as cirrhosis or hepatitis. It is thought that the rash is caused by a buildup of toxins in the body that are normally processed by the liver.
Diagnosing NME can be difficult, as its symptoms can be similar to other skin conditions. A doctor will usually begin by taking a medical history and performing a physical examination. Blood tests may also be ordered to check for signs of liver disease. In some cases, a skin biopsy may be needed to confirm the diagnosis. This involves taking a small sample of skin tissue and examining it under a microscope. This can help to rule out other conditions and confirm the presence of NME.
Treatment for NME usually involves treating the underlying liver disease. This may involve medications, lifestyle changes, or other therapies. In some cases, the rash may improve with treatment of the underlying condition. If the rash does not improve, medications such as topical steroids or antihistamines may be prescribed to reduce the inflammation and itching. In severe cases, phototherapy or other treatments may be necessary.
Necrolytic migratory erythema (NME) is a rare skin condition that is characterized by a distinctive red-brown rash. It is most commonly seen in patients with certain types of liver disease, such as cirrhosis or hepatitis. Diagnosis can be difficult, as its symptoms can be similar to other skin conditions. Treatment usually involves treating the underlying liver disease, and medications such as topical steroids or antihistamines may be prescribed to reduce the inflammation and itching.
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation